| Serial Number | 97164184 |
| Word Mark | LLDX |
| Filing Date | Thursday, December 9, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, June 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 5, 2023 |
| Goods and Services | Gene therapy products, namely, living and genetically engineered tissues for use in predictive and diagnostic medical purposes; medical diagnostic reagents; medical diagnostic reagents and assays for testing and predicting patient recovery; medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; diagnostic test kits for medical use comprising reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising reagents for medical use; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; medical diagnostic reagents and diagnostic reagents for clinical or medical laboratory use, diagnostic reagents for medical in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis comprised of reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes |
| Pseudo Mark | LEUKO LIFE DX |
| Goods and Services | Assays and reagents for research purposes; diagnostic preparations for scientific use; diagnostic reagents for scientific research relating to molecular identification and digital quantification; chemical test kits for scientific research use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation therefor; chemical test kits comprising reagents for scientific research relating to molecular identification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription, and microRNA expression profiling, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits consisting of chemical preparations for scientific research purposes for the detection, diagnosis, progress monitoring and progress prediction of diseases, namely inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing |
| Goods and Services | Medical diagnostic testing, monitoring and reporting services; genetic medical testing service; providing medical information to patients and medical professionals in the form of reports in a wide variety of medical fields; medical services; providing medical information relating to the diagnostic, prophylactic, and therapeutic properties of assays and reagents; providing medical record analysis services designed to provide patients and medical professionals with custom tailored information about the range of possible diagnoses and therapies |
| Goods and Services | Diagnostic test kits for use in microbial testing comprising reagents, slides, solid matrix materials, microfluidic devices, and support documentation therefor |
| Goods and Services | Custom design and development of chemical reagents and biochemical assays; research and product development services for others in the field of biotechnology; providing laboratory research services in the field of gene expression; genetic data mining; development of molecule identification methods for acquiring, analyzing, and managing biological and genetic information, in the fields of genetics research and development services for others in the fields of diagnostic compounds for use in medicine, measuring apparatus for use in product research and development, laboratory separation and purification processes, laboratory testing processes, and industrial quality control processes; developing systems for acquiring, analyzing, and managing biological and genetic information in the fields of diagnostic reagents, forensics, medicine, and genetics; research, design, and development services for others in the fields of diagnostic reagents, compounds and devices, measuring apparatus for use in product research and development, laboratory separation and purification processes, laboratory testing processes, and industrial quality control processes; chemical screening analysis for others |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 14, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 14, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 20, 2023 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 14, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 14, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CAREDX, INC. |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 03 - Corporation |
| Address | BRISBANE, CA 94005 |
| Party Name | LeukoLifeDx, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Rumson, NJ 07760 |
| Party Name | LeukoLifeDx, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Rumson, NJ 07760 |
| Event Date | Event Description |
| Monday, September 19, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, December 13, 2021 | NEW APPLICATION ENTERED |
| Tuesday, December 14, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, September 17, 2022 | ASSIGNED TO EXAMINER |
| Monday, September 19, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, September 19, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, March 17, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 17, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 20, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, April 29, 2023 | NON-FINAL ACTION WRITTEN |
| Saturday, April 29, 2023 | NON-FINAL ACTION E-MAILED |
| Saturday, April 29, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, July 27, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, July 27, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 27, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, July 27, 2023 | ASSIGNED TO EXAMINER |
| Friday, July 28, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 16, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 5, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 31, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, July 12, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, June 3, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, September 5, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, April 17, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |